CSF3 and type 1 diabetes mellitus: The efficacy of low dose ATG (Thymoglobuline) in T1D has been previously reported in three clinical studies where ATG was used as monotherapy as well as in combination therapy with Granulocyte colony-stimulating factor (G-CSF).